Classification of Barrett's epithlium by magnifying endoscopy

Gastrointestinal Endoscopy

Volumn 55, Issue 6, 2002, Pages 641-647

  Endo, Takao ^a,b   Awakawa, Teruhito ^a,b   Takahashi, Hiroaki ^a,b   Arimura, Yoshiaki ^a,b   Itoh, Fumio ^a,b   Yamashita, Kentaro ^a,b   Sasaki, Sigeru ^a,b   Yamamoto, Hiroyuki ^a,b   Tang, Xiufen ^a,b   Imai, Kohzoh ^a,b  

^a Sapporo Medical University ^*

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; MONOCLONAL ANTIBODY KI 67; MUCIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGUS MUCOSA; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; IMMUNOHISTOLOGY; MALE; PHENOTYPE; PRIORITY JOURNAL; STAINING; CLASSIFICATION; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DIGESTIVE TRACT ENDOSCOPY; EPITHELIUM; GENETICS; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STOMACH MUCOSA;

AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, DIGESTIVE SYSTEM; EPITHELIUM; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; MUCINS; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

EID: 19044385199     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.123420     Document Type: Article

References (24)

1. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
2. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
3. Hameetman W, Tytgat GNJ, Houthouf HJ, Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
4. Wright TA, Gray NR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's esophagus. Gut 1996;39:574-9.
5. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
6. Joint statement of ASGE, ACG, and AGA. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Gastrointest Endosc 1998;48: 663-8.
7. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000;52:197-203.
8. Togashi K, Konishi F, Ishizuka T, Sato T, Senba S, Kanazawa K. Efficacy of magnifying endoscopy in the differential diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Dis Colon Rectum 1999;42:1602-8.
9. Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K. Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg 1997;21:694-701.
10. Kudo S, Tamura S, Nakajirna T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14.
11. Cales P, Oberti F, Delmotte JS, Basle M, Casa C, Arnaud JP. Gastric mucosal surface in cirrhosis evaluated by magnifying endoscopy and scanning electronic microscopy. Endoscopy 2000;32:614-23.
12. Canto MI, Setrakian S, Petras RE, Blades E, Chat A, Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;4:1-7.
13. Bara J, Mouradlan GP, Decaens C, Daher N. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer 1991;47:304-10.
14. Pinczower GD, Williams RPW, Gianello RD, Robinson HC, Preston BN, Linnane AW. Characterisation of the tumor-associated carbohydrate epitope recognized by monoclonal antibody 4D3. Int J Cancer 1996;66:636-44.
15. a structure. Biochem Biophys Res Commun 1998;253:374-81.
16. Gerdes J, Becker MH, Key G. Immunohistological detection of tumor growth fraction (Ki67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85-7.
17. Suzuki S, Suzuki H, Endo M, Takemoto T, Kondo T. Endoscopic diagnosis of early cancer and intestinal metaplasia of the stomach by dyeing. Int Surg 1973;58:639-42.
18. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559-65.
19. Endo T, Tamaki K, Arimura Y, Itoh F, Hinoda Y, Hareyama M, et al. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol 1998;33:811-5.
20. Azuma N, Endo T, Arimura Y, Motoya S, Itoh F, Hinoda Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000;35:583-92.
21. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000 18;132:612-20.
22. Clark GWB, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short-segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg 1997;1:113-22.
23. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997; 92:2012-6.
24. Gulizia JM, Wang H, Antonioli D, Spechler SJ, Zeroogian J, Goyal R, et al. Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. Hum Pathol 1999;30:412-8.